Outcomes with anti-EGFR monoclonal antibodies in metastatic and recurrent anal squamous cell carcinoma.
Rogers JE, Jácome AAA, Ohinata A, Wolff R, Morris VK, Johnson B, Mehdizadeh A, Rothschild ND, Ahmed SU, Guerra JL, Eng C.
Rogers JE, et al. Among authors: ohinata a.
Expert Rev Anticancer Ther. 2020 Oct;20(10):901-908. doi: 10.1080/14737140.2020.1810573. Epub 2020 Sep 2.
Expert Rev Anticancer Ther. 2020.
PMID: 32799569